NASDAQ:IMTX

Immatics Biotechnologies Gmbh Stock Insider Trading

etoro logo Buy IMTX
*Your capital is at risk
$10.21
+0.165 (+1.64%)
At Close: Jun 03, 2026

immatics biotechnologies GmbH Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 11.33M and sold 0 IMTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 11.33M shares
Sell 0 shares
100% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Sturchio Edward A Jr
General Counsel
Officer 115 000
Value: $1.04M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Sturchio Edward A Jr
General Counsel
Officer 110 000
Value: $886.6K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Sturchio Edward A Jr
General Counsel
Officer 160 000
Value: $1.49M
Mar 18, 2026
Buy
Restricted Stock Units
Sturchio Edward A Jr
General Counsel
Officer 40 000
Value: $387.2K
Mar 18, 2026
Buy
Ordinary Shares
Silverstein Jordan Zeik
Head Of Strategy
Officer 0
Value: $0
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 53 031
Value: $62.0K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 150 000
Value: $1.50M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 29 000
Value: $280.7K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 60 000
Value: $660.0K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 112 500
Value: $1.10M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 115 000
Value: $1.04M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 110 000
Value: $886.6K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Silverstein Jordan Zeik
Head Of Strategy
Officer 200 000
Value: $1.86M
Mar 18, 2026
Buy
Restricted Stock Units
Silverstein Jordan Zeik
Head Of Strategy
Officer 50 000
Value: $484.0K
Mar 18, 2026
Buy
Ordinary Shares
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 30 939
Value: $32.8K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 145 371
Value: $170.1K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 1 598 000
Value: $16.0M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 168 000
Value: $1.63M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 168 000
Value: $1.85M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 135 000
Value: $1.07M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 388 000
Value: $3.78M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 390 000
Value: $3.53M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 300 000
Value: $2.42M
Mar 18, 2026
Buy
Stock Option (Right to Buy)
Singh Jasuja Harpreet
Chief Executive Officer
CEO / President 753 750
Value: $7.02M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMATICS BIOTECHNOLOGIES GMBH
immatics biotechnologies GmbH
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE